RAPT Therapeutics, Inc. (RAPT)
NASDAQ: RAPT · IEX Real-Time Price · USD
2.790
-0.090 (-3.12%)
At close: Jul 2, 2024, 4:00 PM
2.860
+0.070 (2.51%)
After-hours: Jul 2, 2024, 4:39 PM EDT
RAPT Therapeutics Market Cap
RAPT Therapeutics has a market cap or net worth of $97.38 million as of July 2, 2024. Its market cap has decreased by -86.41% in one year.
Market Cap
97.38M
Enterprise Value
-37.88M
1-Year Change
-86.41%
Ranking
Category
Stock Price
$2.79
Market Cap Chart
Since November 1, 2019, RAPT Therapeutics's market cap has decreased from $270.30M to $97.38M, a decrease of -63.97%. That is a compound annual growth rate of -19.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 100.50M | -88.24% |
| Dec 29, 2023 | 854.70M | 44.33% |
| Dec 30, 2022 | 592.20M | -45.43% |
| Dec 31, 2021 | 1.09B | 123.75% |
| Dec 31, 2020 | 485.00M | -19.54% |
| Dec 31, 2019 | 602.80M | 123.01% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Werewolf Therapeutics | 102.12M |
| Karyopharm Therapeutics | 101.62M |
| Immunic | 100.89M |
| Sagimet Biosciences | 100.85M |
| InflaRx | 100.69M |
| BeyondSpring | 99.54M |
| Armata Pharmaceuticals | 99.43M |
| X4 Pharmaceuticals | 98.98M |